Quiz Time: Which Doctor Group Broke Ties With CDC's Vaccine...
(MedPage Today) — You passed medical training, now see if you can pass our weekly quiz Source link
Health
Explore practical health tips, the latest medical news, and expert wellness advice to help you maintain a balanced and healthy lifestyle every day.
778 results found
Adjuvant Belzutifan-Pembrolizumab Significantly Boosts DFS in Kidney Cancer
(MedPage Today) — SAN FRANCISCO — The adjuvant combination of pembrolizumab (Keytruda) and belzutifan (Welireg) significantly improved disease-free survival (DFS) in patients with clear cell renal cell carcinoma (ccRCC) after...
Living After Suicidality: A Physician's Framework for Healing
(MedPage Today) — I didn’t think about killing myself today. The realization caused me to look up from my epic fantasy book, “Way of Kings.” Seated on my bed as...
GOP Physician Lawmaker Puts Insurers on Notice
(MedPage Today) — Lawmakers have been silent for too long about insurers’ abuses, but all that is about to change, said Rep. Greg Murphy, MD, (R-N.C.) during the American Medical...
More Parents Say 'No' to Vitamin K Shots for Newborns
(MedPage Today) — More parents refused to let newborn children have vitamin K shots, which may lead to vitamin K deficiency bleeding and future brain complications, a systematic literature review...
'Very Impressive' Survival With Combo in First-Line Prostate Cancer Study
(MedPage Today) — SAN FRANCISCO — The first-line combination of olaparib (Lynparza) plus abiraterone (Zytiga) led to a significant overall survival (OS) advantage for patients with metastatic castration-resistant prostate cancer...
No Major 'Reactions' at FDA's Food Allergy Expert Panel
(MedPage Today) — The latest FDA expert panel gave Commissioner Marty Makary, MD, MPH, a chance to sound off on issues close to his heart, but ultimately proved to be...
Better Survival in Refractory CRC With Chemo Plus Bevacizumab, Real-World...
(MedPage Today) — Overall survival (OS) in refractory metastatic colorectal cancer (mCRC) improved significantly with the addition of the VEGF inhibitor bevacizumab (Avastin) to chemotherapy, data from a real-world analysis...
Meningitis B Vaccine Fails to Protect Against Gonorrhea in Trial
(MedPage Today) — DENVER — The four-component meningococcal serogroup B vaccine (4CMenB; Bexsero) did not reduce gonorrhea incidence in high-risk men who have sex with men, according to a randomized...
In-Utero Repair of Severe Spina Bifida With Stem Cells Shows...
(MedPage Today) — In-utero treatment of myelomeningocele, the most severe form of spina bifida, with allogeneic, live stem cells was feasible and safe, a first in-human, phase I, single-arm study...
